2397-768x

npj Precision Oncology

Springer Science and Business Media LLC

View prefix report (10.1038)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 780 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact780 DOIs
2

Add abstracts to 671 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact671 DOIs
3

Deposit reference lists for 140 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact140 DOIs

DOIs for this ISSN

Showing the top 5 of 1559 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Circulating tumor DNA to monitor treatment response in solid… (10.1038/s41698-025-00876-y)
Abstract ORCID
115.59 204
2 Precision oncology- the future of personalized cancer medici… (10.1038/s41698-017-0010-5)
Abstract References ORCID
113.89 32
3 Precision histology: how deep learning is poised to revitali… (10.1038/s41698-017-0022-1)
Abstract ORCID
107.15 138
4 Precision medicine: the foundation of future cancer therapeu… (10.1038/s41698-017-0016-z)
Abstract ORCID
102.27 110
5 Exploring tumor-associated macrophages in glioblastoma: from… (10.1038/s41698-025-00920-x)
Abstract ORCID
95.42 80
6 Recent advances in precision oncology research (10.1038/s41698-018-0055-0)
Abstract ORCID
87.41 55
7 Deep learning models in classifying primary bone tumors and… (10.1038/s41698-025-00855-3)
Abstract ORCID
83.14 45
8 Exploiting tumor aneuploidy as a biomarker and therapeutic t… (10.1038/s41698-023-00492-8)
Abstract ORCID
81.67 42
9 Progress and challenges of artificial intelligence in lung c… (10.1038/s41698-025-00986-7)
Abstract ORCID
81.16 41
10 Artificial intelligence for the next generation of precision… (10.1038/s41698-021-00216-w)
Abstract ORCID
77.20 34
11 Mucin-1: a promising pan-cancer therapeutic target (10.1038/s41698-025-01016-2)
Abstract ORCID
77.20 34
12 Tumor-associated macrophage clusters linked to immunotherapy… (10.1038/s41698-024-00660-4)
Abstract ORCID
75.93 32
13 Multidimensional differences of right- and left-sided colore… (10.1038/s41698-025-00892-y)
Abstract ORCID
73.86 29
14 A machine learning approach for multimodal data fusion for s… (10.1038/s41698-025-00917-6)
Abstract ORCID
73.12 28
15 Author Correction: Genomic context of NTRK1/2/3 fusion-posit… (10.1038/s41698-021-00222-y)
Abstract References ORCID
71.57 8
16 Multi-omics in immunotherapy research for HNSCC: present sit… (10.1038/s41698-025-00886-w)
Abstract ORCID
71.57 26
17 The therapeutic potential of resveratrol: a review of clinic… (10.1038/s41698-017-0038-6)
ORCID
70.67 670
18 ALYREF recruits ELAVL1 to promote colorectal tumorigenesis v… (10.1038/s41698-024-00737-0)
Abstract ORCID
69.01 23
19 The role of the gut microbiota in chemotherapy response, eff… (10.1038/s41698-025-01034-0)
Abstract ORCID
69.01 23
20 MRI transformer deep learning and radiomics for predicting I… (10.1038/s41698-025-00884-y)
Abstract ORCID
68.09 22
21 PharmaFormer predicts clinical drug responses through transf… (10.1038/s41698-025-01082-6)
Abstract ORCID
68.09 22
22 Deciphering the cellular and molecular landscape of cervical… (10.1038/s41698-025-00948-z)
Abstract ORCID
67.12 21
23 A framework for artificial intelligence in cancer research a… (10.1038/s41698-023-00383-y)
Abstract ORCID
66.11 20
24 Integrative multi-omics and machine learning reveal critical… (10.1038/s41698-025-01027-z)
Abstract ORCID
66.11 20
25 Targeting CDKs in cancer therapy: advances in PROTACs and mo… (10.1038/s41698-025-00931-8)
Abstract ORCID
65.05 19
26 Leveraging artificial intelligence in antibody-drug conjugat… (10.1038/s41698-025-01159-2)
Abstract ORCID
65.05 19
27 The role of tumor necrosis factor receptor superfamily in ca… (10.1038/s41698-025-00990-x)
Abstract ORCID
63.94 18
28 Neoadjuvant immune checkpoint inhibitors for hepatocellular… (10.1038/s41698-025-00846-4)
Abstract ORCID
62.76 17
29 Organotropism: new insights into molecular mechanisms of bre… (10.1038/s41698-018-0047-0)
ORCID
62.07 303
30 Immune-related cell death index and its application for hepa… (10.1038/s41698-024-00693-9)
Abstract ORCID
61.52 16
31 Immunotherapy in lung cancer brain metastases (10.1038/s41698-025-00901-0)
Abstract ORCID
61.52 16
32 Multi-omics analyses reveal interactions between GREM1+ fibr… (10.1038/s41698-025-00967-w)
Abstract ORCID
61.52 16
33 IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3… (10.1038/s41698-025-01041-1)
Abstract ORCID
61.52 16
34 A real-world cohort study of immune-related adverse events i… (10.1038/s41698-025-01123-0)
Abstract ORCID
61.52 16
35 Development and validation of machine learning models for yo… (10.1038/s41698-024-00719-2)
Abstract ORCID
60.21 15
36 Benchmarking large language models GPT-4o, llama 3.1, and qw… (10.1038/s41698-025-00935-4)
Abstract ORCID
60.21 15
37 TREM2-mediated regulation of myeloid cells in the tumor micr… (10.1038/s41698-025-01152-9)
Abstract ORCID
60.21 15
38 Role of nonresolving inflammation in hepatocellular carcinom… (10.1038/s41698-018-0048-z)
ORCID
59.99 250
39 Bio-primed machine learning to enhance discovery of relevant… (10.1038/s41698-025-00825-9)
Abstract ORCID
58.80 14
40 Tertiary lymphoid structures associated with improved surviv… (10.1038/s41698-025-00891-z)
Abstract ORCID
58.80 14
41 Single cell analysis revealed SFRP2 cancer associated fibrob… (10.1038/s41698-024-00716-5)
Abstract ORCID
57.31 13
42 Bifidobacterium boosts anti-PD-1 effectiveness through JAK p… (10.1038/s41698-025-00960-3)
Abstract ORCID
57.31 13
43 Spatial transcriptomics reveals macrophage domestication by… (10.1038/s41698-025-01005-5)
Abstract ORCID
57.31 13
44 Interaction between Wnt/β-catenin and RAS-ERK pathways and a… (10.1038/s41698-018-0049-y)
ORCID
56.85 187
45 Zebrafish Avatar testing preclinical study predicts chemothe… (10.1038/s41698-025-00882-0)
Abstract ORCID
55.70 12
46 Foundation model-driven multimodal prognostic prediction in… (10.1038/s41698-025-00900-1)
Abstract ORCID
55.70 12
47 Immunotherapy for diffuse gastric cancer: challenges and new… (10.1038/s41698-025-01052-y)
Abstract ORCID
55.70 12
48 Pan cancer research reveals the role of PTGDS in tumor suppr… (10.1038/s41698-025-01097-z)
Abstract ORCID
55.70 12
49 The evolving landscape of antibody-drug conjugates (ADCs) fo… (10.1038/s41698-025-01131-0)
Abstract ORCID
55.70 12
50 KRAS-targeted therapies in colorectal cancer: a systematic a… (10.1038/s41698-025-01166-3)
Abstract ORCID
55.70 12